Skip to content
In English |
En español
Search
Clinical Trials Search Results
Page Options
E-Mail This Search
Clinical Trial Questions?
Get Help:
1-800-4-CANCER
or
LiveHelp online chat
Quick Links
Help Using the NCI Clinical Trials Search Form
Educational Materials About Clinical Trials
About NCI's Cancer Clinical Trials Registry
Dictionary of Cancer Terms
NCI Drug Dictionary
View Content for:
Patients
Health Professionals
Display:
Title
Description with:
Locations
Eligibility
Full Trial Description
Custom
Results 1-25 of 37 for your search:
Cancer Type/Condition:
Testicular germ cell tumor
Stage/Subtype:
stage III testicular germ cell tumor
Trial Type:
Treatment
Trial Status:
Active
Hide Search Criteria
Show Search Criteria
Help with Results
Select All on Page
Sort by:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Show
10
25
50
100
200
Results per Page
1.
Trial of Levofloxacin as Prophylaxis After Allogeneic Stem Cell Transplantation (SCT)
Phase:
Phase III, Phase II
Type:
Supportive care, Treatment
Status:
Active
Age:
Not specified
Sponsor:
Other
Protocol IDs:
Levosta-CBF-02/04
, NCT00215007
2.
Phase III Randomized Study of Bleomycin, Etoposide, and Cisplatin With or Without Dose-Dense Sequential Combination Chemotherapy in Patients With Poor Prognosis Stage II or III Non-Seminomatous Germ Cell Tumors
Phase:
Phase III
Type:
Treatment
Status:
Active
Age:
Over 16
Sponsor:
Other
Protocol IDs:
FRE-FNCLCC-GETUG-13/0206
, EU-20502, NCT00104676
3.
Phase III Randomized Study of Short- Versus Long-Infusion Schedule of Bleomycin in Patients Who are Undergoing Combination Chemotherapy Comprising Bleomycin, Etoposide, and Cisplatin for Good-Prognosis, Metastatic Germ Cell Cancer of the Testes
Phase:
Phase III
Type:
Treatment
Status:
Active
Age:
18 to 50
Sponsor:
Other
Protocol IDs:
BARTS-TE3
, EU-20608, ISRCTN08648791, NCT00324298
4.
A Multicentre Randomised Controlled Trial Comparing Two Strategies for the Diagnosis of Invasive Aspergillosis in High-Risk Haematology Patients
Phase:
Phase III
Type:
Diagnostic, Treatment
Status:
Active
Age:
18 to 80
Sponsor:
Other
Protocol IDs:
55/05
, ALLG SC01, NHMRC Project Grant 331305, NCT00163722
5.
Budesonide for Prevention of Acute Gastrointestinal GVHD Following Allogenic Stem Cell Transplantation
Phase:
Phase III
Type:
Supportive care, Treatment
Status:
Active
Age:
12 to 65
Sponsor:
Other
Protocol IDs:
PROGAST
, NCT00180089
6.
Phase I/II Study of Pentostatin and Donor Lymphocyte Infusion in Preventing Graft Rejection in Cancer Patients With Low or Falling Donor T-Cell Chimerism After Nonmyeloablative Allogeneic Stem Cell Transplantation
Phase:
Phase II, Phase I
Type:
Treatment
Status:
Active
Age:
Under 75
Sponsor:
NCI, Pharmaceutical / Industry
Protocol IDs:
FHCRC-1825.00
, 5605, SUPERGEN-FHCRC-1825.00, NCT00096161
7.
Phase I/II Study of Paclitaxel and Ifosfamide Followed By Paclitaxel, Carboplatin, and Ifosfamide With Autologous Peripheral Blood Stem Cell Support in Patients With Cisplatin-Resistant Germ Cell Tumor
Phase:
Phase II, Phase I
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
MSKCC-06077
, NCT00423852
8.
Evaluation of Single Session Stereotactic Body Radiotherapy
Phase:
Phase II, Phase I
Type:
Treatment
Status:
Active
Age:
Not specified
Sponsor:
Other
Protocol IDs:
2005-0445
, NCT00492817
9.
Open-Label Study Designed to Evaluate the Safety and Preliminary Efficacy of ApoCell for the Prevention of Acute GvHD
Phase:
Phase II, Phase I
Type:
Supportive care, Treatment
Status:
Approved-not yet active
Age:
18 to 55
Sponsor:
Other
Protocol IDs:
ApoCell-I-IIa
, NCT00524784
10.
Phase I/II Study of Gemcitabine Hydrochloride, Paclitaxel, Ifosfamide, and Cisplatin as Salvage Chemotherapy in Patients With Progressive or Relapsed Metastatic Germ Cell Tumors
Phase:
Phase II, Phase I
Type:
Treatment
Status:
Active
Age:
16 to 60
Sponsor:
Other
Protocol IDs:
USCTU-UR1002-GEM-TIP
, UR1002-Gem-TIP, EU-20769, EUDRACT-2004-004804-19, NCT00551122
11.
Trial of Gemcitabine, Cisplatin, and Ifosfamide in Patients With Relapsed Non-Seminomatous Germ-Cell Tumors
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
16 and over
Sponsor:
Other
Protocol IDs:
GIP-TG
, NCT00127049
12.
Study of Gemcitabine, Oxaliplatin, and Paclitaxel in Patients With Refractory Germ Cell Carcinoma
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
16 and over
Sponsor:
Other
Protocol IDs:
4T-03-1
, NCT00183820
13.
Phase II Randomized Study of Intensive Induction Chemotherapy Comprising Cisplatin, Vincristine, Bleomycin, and Carboplatin Followed By Bleomycin, Etoposide Phosphate, and Cisplatin (BEP) Versus Standard BEP Chemotherapy in Male Patients With Poor-Prognosis Extracranial Nonseminoma Germ Cell Tumors
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
16 and over
Sponsor:
Other
Protocol IDs:
MRC-TE23
, EU-205107, ISRCTN53643604, EUDRACT-2004-000405-22, NCT00301782
14.
Phase II Randomized Study of Zoledronic Acid in Preventing Osteoporosis in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
Phase:
Phase II
Type:
Supportive care, Treatment
Status:
Active
Age:
18 and over
Sponsor:
NCI, Pharmaceutical / Industry
Protocol IDs:
UMN-2005NT018
, UMN-0506M70866, UMN-MT2005-06, NOVARTIS-CZOL446EUS29, NCT00321932
15.
Study of Oxaliplatin Plus Bevacizumab in Germ Cell Tumor Patients
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
Other
Protocol IDs:
0609-11
, IUCRO-0166, AVF4003s, NCT00393861
16.
Study of a Non-Cross-Resistant Conditioning Regimen Followed By Single or Tandem Autologous Peripheral Blood Stem Cell Transplantation in Patients With Germ Cell Tumors
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
10 to 69
Sponsor:
NCI
Protocol IDs:
UMN-2006LS032
, UMN-MT2005-21, UMN-0608M90586, NCT00432094
17.
Tocopherol is a Novel Treatment for Cancer Related Mucositis
Phase:
Phase II
Type:
Supportive care, Treatment
Status:
Approved-not yet active
Age:
18 and over
Sponsor:
Other
Protocol IDs:
270505-HMO-CTIL
, NCT00162526
18.
Phase II Pilot Study of Bleomycin, Etoposide, Cisplatin, and Pegfilgrastim in Men With Metastatic Germ Cell Tumors
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
18 to 40
Sponsor:
Other
Protocol IDs:
CRCA-CCTC-ACCELERATED-BEP
, CCTC-ACCELERATED-BEP, EUDRACT-2004-000847-79, EU-20713, NCT00453232
19.
Phase II Pilot Study of Irradiated Allogeneic Related Donor Lymphocyte Infusion in Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor
Phase:
Phase II
Type:
Biomarker/Laboratory analysis, Treatment
Status:
Active
Age:
Any age
Sponsor:
NCI
Protocol IDs:
CINJ-3330
, NCT00161187
20.
Phase II Study of Combination Chemotherapy and Pegfilgrastim in Patients With Previously Untreated Germ Cell Tumors
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
MSKCC-07044
, 07-044, NCT00470366
21.
Phase II Study of Conditioning Regimen Comprising Anti-thymocyte Globulin, Clofarabine, and Rituximab in Patients With Primary or Secondary Graft Failure After Hematopoietic Stem Cell Transplantation
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
Not specified
Sponsor:
NCI
Protocol IDs:
UMN-2007LS072
, UMN-2007LS072, UMN-MT2007-07, NCT00617929
22.
Phase II Study of Tandem High-Dose Chemotherapy in Combination With Autologous Hematopoietic Stem Cell Transplantation in Patients With Germ Cell Tumors
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
16 and over
Sponsor:
NCI
Protocol IDs:
FHCRC-07156
, 07156, CHNMC-07156, NCT00627601
23.
Trial Of Double Umbilical Cord Blood Transplantation
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
65 and under
Sponsor:
Other
Protocol IDs:
umcc 2007.137
, HUM00017515, NCT00763490
24.
Sorafenib Monotherapy in Inoperable/Recurrent Germ Cell Carcinoma Refractory to Chemotherapy
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
18 to 75
Sponsor:
Other
Protocol IDs:
12602
, PL/ 183/UR/CEBK/04/08, EudraCT 2007-007599-40, NCT00772694
25.
Busulfan Plus Cyclophosphamide vs Fludarabine as a Conditioning Regimen for Allogeneic Hematopoietic Cell Transplantation in Leukemia and Myelodysplastic Syndrome
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
15 to 69
Sponsor:
Other
Protocol IDs:
C-005
, NCT00774280
Select All on Page
1
Help with Results
NCI Home
|
Text-Only Version
|
Contact Us
|
Policies
|
Accessibility
|
RSS
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute
